|
Volumn 30, Issue 7, 2008, Pages 561-563
|
Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
FOLIC ACID;
LACTATE DEHYDROGENASE;
VITAMIN B COMPLEX;
ADVERSE OUTCOME;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
COMORBIDITY;
HEALTH HAZARD;
HIGH RISK PATIENT;
HUMAN;
HYPERTRANSAMINASEMIA;
LACTATE DEHYDROGENASE BLOOD LEVEL;
LETTER;
LOW RISK PATIENT;
MATERNAL HYPERTENSION;
OBESITY;
PRACTICE GUIDELINE;
PREECLAMPSIA;
PREPREGNANCY CARE;
RECOMMENDED DRUG DOSE;
RISK ASSESSMENT;
RISK FACTOR;
SYMPTOM;
VITAMIN SUPPLEMENTATION;
BLOOD;
FEMALE;
HYPERTENSION;
MATERNAL CARE;
PREGNANCY;
PREGNANCY COMPLICATION;
ALANINE TRANSAMINASE;
ASPARTATE AMINOTRANSFERASES;
FEMALE;
FOLIC ACID;
HUMANS;
HYPERTENSION;
L-LACTATE DEHYDROGENASE;
PRECONCEPTION CARE;
PREGNANCY;
PREGNANCY COMPLICATIONS, CARDIOVASCULAR;
VITAMIN B COMPLEX;
|
EID: 79953329484
PISSN: 17012163
EISSN: None
Source Type: Journal
DOI: 10.1016/S1701-2163(16)32885-7 Document Type: Letter |
Times cited : (4)
|
References (3)
|